Skip to content

Outcomes of Bilateral Implantation of an Enhanced Monofocal Intraocular Lens

Visual Outcomes of a New Monofocal Intraocular Lens With Modified Optical Profile: a Randomized Controlled Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06118944
Acronym
RCT_ICB00
Enrollment
90
Registered
2023-11-07
Start date
2019-11-11
Completion date
2023-01-31
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

IOL, intermediate distance, cataract surgery, enhanced monofocal

Brief summary

To evaluate and compare the visual outcomes of an enhanced monofocal intraocular lens (IOL) with two different monofocal IOLs in patients scheduled for bilateral cataract surgery.

Detailed description

The main objective of the study is the evaluation and comparison of the clinical outcomes of three parallel groups of patients after bilateral implantation of ICB00 IOL or ZCB00 IOL or CNA0T0 IOL respectively. The ICB00 IOL is a modified monofocal IOL. Compared to other monofocal IOLs, its modified optical design was created to provide improved intermediate vision, comparable distance vision and a profile of dysphotopsia similar to other monofocal lenses. Considering the modified optical profile of the ICB00 IOL, the primary objective will be the evaluation of visual performance at intermediate distance.

Interventions

DEVICEICB00 IOL

Bilateral implantation of ICB00 IOL

DEVICEZCB00 IOL

Bilateral implantation of ZCB00 IOL

DEVICECNA0T0 IOL

Bilateral implantation of CNA0T0 IOL

Sponsors

University of Trieste
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* clinically significant bilateral cataract (BCVA \<20/40, cataract must be the primary cause of visual impairment) * axial length between 21 and 27 mm * the patient must be able to read, understand and provide written informed consent, * the patient must be willing and able to comply with all study and follow-up procedures * preoperative refractive cylinder ≤ 0.75 D

Exclusion criteria

* anterior segment pathology that could significantly affect results (e.g., chronic uveitis, iritis, corneal dystrophy, keratoconus) * diabetic retinopathy * uncontrolled glaucoma and/or intraocular pressure IOP\> 24 mmHg * all types of infections (acute eye disease, external/internal infection, systemic infection) * traumatic cataract * pupillary abnormalities including aniridia and/or pupil diameter in mesopic conditions in distance vision ≤ 2.5 mm and ≥ 6 mm * microphthalmia * amblyopia * degenerative visual disorders (for example macular degeneration, optic nerve atrophy or retinal disorders) * previous intraocular and corneal surgery * systemic or ocular pharmacotherapy, which may impact visual acuity and/or cause floppy iris syndrome and/or insufficient dilation in the opinion of the investigator * patients who are unable to fixate for a prolonged time (e.g. strabismus, nystagmus) * period of pregnancy or breastfeeding for female patients

Design outcomes

Primary

MeasureTime frameDescription
Bino DCIVA12 weeks after second eye surgeryBinocular distance corrected intermediate visual acuity

Secondary

MeasureTime frameDescription
Mono UIVA12 weeks after second eye surgeryMonocular uncorrected intermediate visual acuity
Bino UIVA12 weeks after second eye surgeryBinocular uncorrected intermediate visual acuity
Mono UDVA12 weeks after second eye surgeryMonocular uncorrected distance visual acuity
Bino UDVA12 weeks after second eye surgeryBinocular uncorrected distance visual acuity
Mono BCDVA12 weeks after second eye surgeryMonocular best corrected distance visual acuity
Bino BCDVA12 weeks after second eye surgeryBinocular best corrected distance visual acuity
Mono DCIVA12 weeks after second eye surgeryMonocular distance corrected intermediate visual acuity
Bino UNVA12 weeks after second eye surgeryBinocular uncorrected near visual acuity
Mono CNVA12 weeks after second eye surgeryMonocular corrected near visual acuity
Bino CNVA12 weeks after second eye surgeryBinocular corrected near visual acuity
Binocular defocus curves12 weeks after second eye surgeryBinocular defocus curves in photopic conditions (from -4 D up to +2.00 D)
Catquest 9SF score changespreop and 12 weeks after second eye surgeryChanges in Catquest 9SF score before and 3 months after surgery
Mono UNVA12 weeks after second eye surgeryMonocular uncorrected near visual acuity

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026